Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Zifo has launched an AI enabled data migration solution that automates complex scientific data transfers while maintaining compliance and validation for industries such as biopharma.
Datar Cancer Genetics has received U.S. FDA clearance for its CellDx Tissue assay, a comprehensive genomic profiling test for solid tumors that analyzes DNA and RNA to identify key cancer-related genetic variations.
Ozelle received the German Innovation Award Gold for its EHBT-50 Mini Lab, a multifunctional diagnostic system that integrates hematology, biochemistry, immunoassay, and AI-assisted morphology analysis into one platform designed for decentralized clinical environments.
Varda Space Industries and United Therapeutics have announced a collaboration to study drug formulation in microgravity, aiming to develop improved treatments for rare pulmonary diseases using Varda's orbital manufacturing platform.
The American Society of Gene & Cell Therapy and Orphan Therapeutics Accelerator have launched CGTxchange, an AI-enhanced marketplace designed to reactivate promising but shelved cell and gene therapy programs. The platform is live with pilot assets and now accepting applications from sponsors.
Cantex Pharmaceuticals and Headlamp Health have announced a partnership to use Headlamp's Lumos AI platform to accelerate the development of azeliragon for treating severe depression and fatigue in multiple sclerosis patients.
Global Healthcare Exchange (GHX) has introduced a new AI-powered orchestration layer to help healthcare providers and suppliers detect disruptions earlier and coordinate faster across supply chain workflows. The launch was announced at the GHX Summit in New Orleans.
Natus Medical Incorporated has established a Global EEG Advisory Board composed of clinical experts to advise on product development, AI integration, and workflow improvements in neurodiagnostics.
Corti has launched a Startup Acceleration Program to help healthcare AI founders address regulatory and technical challenges in Europe and the U.S. The program offers access to Corti’s clinical-grade Symphony models and regulatory guidance for startups worldwide.
SOPHiA GENETICS has partnered with Synnovis to introduce liquid biopsy testing for lung and breast cancer patients across the UK, supporting NHS England's new blood test-first program.
Cellular Intelligence has obtained global rights to Novo Nordisk's clinical-stage Parkinson's cell therapy and will apply its AI platform to accelerate development and manufacturing, while Novo Nordisk takes an equity stake.
Elsevier's Clinician of the Future 2026 report shows that nurses are being left out of decisions on adopting clinical AI tools, with only 41% reporting regular use compared to 57% of physicians.
VentriPoint Diagnostics will present its AI-powered cardiac imaging system, VMS+ 4.0, at the Association for European Paediatric and Congenital Cardiology annual meeting in Italy. The company is also expanding regulatory submissions and partnerships across multiple regions.
Aon has expanded its Aon Claims Copilot platform worldwide, integrating advanced analytics and claims data into one unified system to enhance transparency and consistency across client claims management.
AndzonBio2 has entered a collaboration with the University of Cambridge's ALBORADA Drug Discovery Institute and Cambridge Enterprise to develop a new class of therapeutics targeting neuroinflammation, a key factor in neurodegenerative diseases.
H.I.G. Capital announced that its portfolio company Avanta Salud has signed an agreement to acquire Vitaly Group, combining two major occupational health and safety providers in Iberia.
Phylex BioSciences has developed an AI derived mRNA nanoparticle vaccine candidate for the Andes hantavirus within two days of the virus sequence being posted by Geneva University Hospitals.
Pointcare has introduced an upgraded coverage advocacy platform that offers real time coverage visibility, household enrollment, and automated renewal management for patients on Medicaid, Medicare, and Marketplace plans.
The Department of Health Abu Dhabi and Fred Hutchinson Cancer Center have signed a memorandum of understanding to collaborate on cancer research and personalized prevention using Abu Dhabi's AI health infrastructure and genomic data systems.
BranchLab has secured $26 million in Series A funding led by McKesson Ventures, with participation from FCA Venture Partners, Sanofi Ventures, and AIX Ventures, to expand its AI platform for pharmaceutical commercialization.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
